Clinical Trial Update: Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and effectiveness of the dapivirine vaginal ring for HIV-1 prevention in women has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2022-12-16